Risk scores versus natriuretic peptides for identifying prevalent stage B heart failure.

@article{Gupta2011RiskSV,
  title={Risk scores versus natriuretic peptides for identifying prevalent stage B heart failure.},
  author={Sachin Gupta and Anand K. Rohatgi and Colby R. Ayers and Parag C Patel and Susan A. Matulevicius and Ronald M. Peshock and David W Markham and James A. de Lemos and Jarett D. Berry and Mark H. Drazner},
  journal={American heart journal},
  year={2011},
  volume={161 5},
  pages={923-930.e2}
}
BACKGROUND Identifying asymptomatic individuals with American Heart Association/American College of Cardiology stage B heart failure (HF) in the population is an important step to prevent the development of symptomatic HF. The comparative utility of 2 screening strategies (biomarkers vs risk scores) in identifying prevalent stage B HF is unknown. METHODS Participants 30 to 65 years old without symptomatic HF in the Dallas Heart Study who had a cardiac magnetic resonance imaging were included… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

Preventing heart failure: a critique of strategies.

Journal of cardiac failure • 2013
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 21 references

ACC/AHA 2005 guideline update: chronic heart failure in the adult.

JAAPA : official journal of the American Academy of Physician Assistants • 2006
View 1 Excerpt

Acc / Aha

SA Hunt
2005

Similar Papers

Loading similar papers…